Please consult your health care provider for specific recommendations regarding your digestive health. This post is for informational purposes only and not specific medical advice. Do not delay medical attention based on information discussed here.
[caption id="attachment_67268" align="aligncenter" width="500"]
Image source[/caption]
Our digestive system is essential for overall health, yet millions experience gastrointestinal disorders each year. Issues like acid reflux, peptic ulcers, and inflammatory bowel disease are becoming more common. When left undiagnosed or untreated, these conditions can lead to severe complications, impacting daily life and long-term well-being.
Endoscopy has become an essential tool in diagnosing GI disorders. In this blog post, we’ll talk about endoscopy in managing GI disorders.
However, if you’re experiencing persistent digestive issues, always search for an endoscopy specialist near me on Google to get an accurate diagnosis. They can offer tailored treatment options, ensuring better outcomes and improved quality of life.
Image source[/caption]
Our digestive system is essential for overall health, yet millions experience gastrointestinal disorders each year. Issues like acid reflux, peptic ulcers, and inflammatory bowel disease are becoming more common. When left undiagnosed or untreated, these conditions can lead to severe complications, impacting daily life and long-term well-being.
Endoscopy has become an essential tool in diagnosing GI disorders. In this blog post, we’ll talk about endoscopy in managing GI disorders.
However, if you’re experiencing persistent digestive issues, always search for an endoscopy specialist near me on Google to get an accurate diagnosis. They can offer tailored treatment options, ensuring better outcomes and improved quality of life.
Prof. Dubinsky[/caption]
Marla Dubinsky, M.D.
Professor of Pediatrics and Medicine
Co-director of the Susan and Leonard Feinstein IBD Clinical Center
Chief of the Division of Pediatric Gastroenterology and Nutrition
Icahn School of Medicine at Mount Sinai
MedicalResearch.com: What is the background for this study? How does MIRIKIZUMAB differ from other medications for UC?
Response: This is a phase 2 study to assess the PK (pharamcokinetics), safety and efficacy of mirikizumab in pediatric ulcerative colitis (UC).
Dr. Zhongshang Yuan[/caption]
Yuan, Zhongshang PhD
Department of Biostatistics
School of Public Health
Shandong University
Jinan, Shandong, China
What is the background for this study?
Response: Comorbidities and genetic correlations between gastrointestinal tract diseases and psychiatric disorders have been widely reported, with the gut-brain axis (GBA) hypothesized as a potential biological basis. However, it is unclear the degree to which the shared genetic determinants contribute to these associations underlying GBA.